Stocks · Health care · Biological Products, (No Diagnostic Substances)

Taysha Gene Therapies, Inc.

TSHA Clue Score55

United States Fiscal year ends December CIK 0001806310 Results filed 11 Aug 2026

Add to watchlist

What the insiders did Net selling

Bought (12 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$6.66M

$1.25M on a plan · $3.53M straight out of an exercise

Sold at will

$1.88M

7 of 12 sales

Net

−$6.66M

−$1.88M against sales at will